Sotyktu

Active Ingredient(s): Deucravacitinib
FDA Approved: * September 9, 2022
Pharm Company: * BRISTOL-MYERS SQUIBB
Category: Immunosuppressive
* May have multiple approval dates, manufacturers, or labelers.